Gene · 1293
Papers2,433
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,433
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel variations in three cases with rare inherited neuromuscular disorder. | Exp Ther Med | 2024 | 38756899 | PubTator, text mining | PubMed |
| Prediction of novel biomarkers for gastric intestinal metaplasia and gastric adenocarcinoma using bioinformatics analysis. | Heliyon | 2024 | 38737262 | PubTator, text mining | PubMed |
| Benfotiamine improves dystrophic pathology and exercise capacity in mdx mice by reducing inflammation and fibrosis. | Hum Mol Genet | 2024 | 38710523 | PubTator, text mining | PubMed |
| Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study. | Brain Behav Immun | 2024 | 38710337 | PubTator, text mining | PubMed |
| Periostin Is a Biomarker for Anterior Shoulder Instability: Proteomic Analysis of Synovial Fluid. | Am J Sports Med | 2024 | 38702960 | PubTator, text mining | PubMed |
| Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn's disease. | J Cell Mol Med | 2024 | 38685679 | PubTator, text mining | PubMed |
| Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis. | Int J Mol Sci | 2024 | 38673990 | PubTator, text mining | PubMed |
| Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy. | Mol Ther Nucleic Acids | 2024 | 38617974 | PubTator, text mining | PubMed |
| [Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 38597453 | PubTator, text mining | PubMed |
The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy. | medRxiv | 2024 | 38585825 | PubTator, text mining | PubMed |
| Splicing Switching of Alternative Last Exons Due to a Deletion Including Canonical Polyadenylation Site in COL6A2 Gene Causes Recessive UCMD. | Neurol Genet | 2024 | 38544966 | PubTator, text mining | PubMed |
| Integrative cross-species analysis reveals conserved and unique signatures in fatty skeletal muscles. | Sci Data | 2024 | 38472209 | PubTator, text mining | PubMed |
| Trisomy 21 Alters Cell Proliferation and Migration of iPSC-Derived Cardiomyocytes on Type VI Collagen. | Cell Mol Bioeng | 2024 | 38435791 | PubTator, text mining | PubMed |
| A Comprehensive Review of Muscle-Tendon Junction: Structure, Function, Injury and Repair. | Biomedicines | 2024 | 38398025 | PubTator, text mining | PubMed |
| System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis. | Heliyon | 2024 | 38322840 | PubTator, text mining | PubMed |
| Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics. | iScience | 2024 | 38303703 | PubTator, text mining | PubMed |
| TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer. | Breast Cancer Res | 2024 | 38297352 | PubTator, text mining | PubMed |
| Analysis of subsets and localization of macrophages in skin lesions and peripheral blood of patients with keloids. | Heliyon | 2024 | 38283250 | PubTator, text mining | PubMed |
| COL6A3 enhances the osteogenic differentiation potential of BMSCs by promoting mitophagy in the osteoporotic microenvironment. | Mol Biol Rep | 2024 | 38270688 | PubTator, text mining | PubMed |
| Single-cell landscape of the cellular microenvironment in three different colonic polyp subtypes in children. | Clin Transl Med | 2024 | 38264936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1293/papers?page=9